Approval · Notice of Compliance 5699 · 1994
HYDROMORPH CONTIN: Notice of Compliance 5699
Issued August 9, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5699
- Date
- August 9, 1994
- Company
- Purdue Frederick
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Narcotic analgesic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| HYDROMORPH CONTIN | 02125323 | Marketed |
| HYDROMORPH CONTIN | 02125331 | Marketed |
| HYDROMORPH CONTIN | 02125358 | — |
| HYDROMORPH CONTIN | 02125366 | Marketed |
| HYDROMORPH CONTIN | 02125374 | — |
| HYDROMORPH CONTIN | 02125382 | Marketed |
| HYDROMORPH CONTIN | 02125390 | Marketed |
Medicinal ingredients
- HYDROMORPHONE HCL 3 MG per CAP
- HYDROMORPHONE HCL 6 MG per CAP
- HYDROMORPHONE HCL 10 MG per CAP
- HYDROMORPHONE HCL 12 MG per CAP
- HYDROMORPHONE HCL 20 MG per CAP
- HYDROMORPHONE HCL 24 MG per CAP
- HYDROMORPHONE HCL 30 MG per CAP